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Enteroaggregative Escherichia coli (EAEC) is increasingly being recognized as a cause of diarrheal disease
in diverse populations. No small animal model is currently available to study this pathogen. We report here
that conventional mice orally inoculated with prototype EAEC strain 042 generally became colonized, though
the abundance of organisms cultured from their stool varied substantially among individual animals. In
contrast, mice whose water contained 5 g/liter streptomycin consistently became colonized at high levels (ca.
108 CFU/g of stool). Neither conventional nor streptomycin-treated mice developed clinical signs or histopatho-
logic abnormalities. Using specific mutants in competition with the wild-type strain, we evaluated the contri-
bution of several putative EAEC virulence factors to colonization of streptomycin-treated mice. Our data
suggest that the dispersin surface protein and Pic, a serine protease autotransporter secreted by EAEC and
Shigella flexneri, promote colonization of the mouse. In contrast, we found no role for the aggregative adherence
fimbriae, the transcriptional activator AggR, or the surface factor termed Air (enteroaggregative immunoglob-
ulin repeat protein). To study Pic further, we constructed a single nucleotide mutation in strain 042 which
altered only the Pic catalytic serine (strain 042PicS258A). Fractionation of the tissue at 24 h and 3 days
demonstrated an approximate 3-log10 difference between 042 and 042PicS258A in the lumen and mucus layer
and adherent to tissue. Strains 042 and 042PicS258A adhered similarly to mouse tissue ex vivo. While no
growth differences were observed in a continuous-flow anaerobic intestinal simulator system, the wild-type
strain exhibited a growth advantage over 042PicS258A in a culture of cecal mucus and in cecal contents in
vitro; this difference was manifest only after 6 h of growth. Moreover, enhanced growth of the wild type was
observed in comparison with that of the mutant in minimal medium containing mucin but not in the absence
of mucin. The data suggest a novel metabolic role for the Pic mucinase in EAEC colonization.
Enteroaggregative Escherichia coli (EAEC) is an emerging
agent of diarrheal illness in multiple epidemiologic settings
(19). The pathogen has been associated with persistent diar-
rhea in children (4, 5), acute endemic diarrhea (38), persistent
diarrhea in AIDS patients (13), food-borne outbreaks (20),
and traveler’s diarrhea (1). Pathogenesis is believed to occur in
the ileum and colon, where the bacteria adhere in a thick,
aggregating biofilm, mediated by aggregative adherence fim-
briae (AAFs) (7, 21, 28). Following adherence, EAEC causes
tissue damage and fluid secretion by elaborating one or more
enterotoxins, including the Pet cytotoxin (31), EAST1 (39)
and/or ShET1 (11, 12).
Adherence to human intestinal mucosa ex vivo requires the
expression of AAFs (7), although additional colonization fac-
tors are likely to contribute. We have also described dispersin,
a 10-kDa hydrophilic protein which attaches noncovalently to
the bacterial cell surface (40). Both dispersin and AAF/II, the
AAF allele expressed by strain 042, are under the control of
the transcriptional activator AggR (7, 30, 40). In the absence of
dispersin, AAF pili collapse onto the surface of the cells, and
the bacteria display a hyperaggregative phenotype (40). We
have also shown, however, that dispersin mutants are impaired
in their abilities to penetrate an artificial mucus layer (40), and
they may therefore be paradoxically more adherent but less
adept at colonization. In addition, EAEC genome character-
ization has identified an adhesin called Air (enteroaggregative
immunoglobulin repeat protein), which features a large num-
ber of immunoglobulin-like repeats and which may promote
bacterial aggregation and colonization (41).
In addition to toxins and adhesins, EAEC secretes Pic, a
protein with hemagglutinin and mucinolytic activity in vitro
(17). Some epidemiologic studies suggest a role for pic or its
linked genes in EAEC disease (35). Notably, pic alleles are also
present in Shigella flexneri 2a (36) and in uropathogenic E. coli
(UPEC) strains (16). Guyer et al. found pic to be more com-
mon among pyelonephritis isolates than fecal strains, suggest-
ing a role in urinary tract infections (15, 34). In the CBA mouse
model of ascending urinary tract infections, wild-type UPEC
tended to colonize better than a pic mutant (16); however, this
difference did not reach statistical significance, and further
studies have not been reported.
Pic is a 116-kDa secreted autotransporter protein of the
SPATE (serine protease autotransporter of enterobacteri-
aceae) family (18). Sequence alignments and functional com-
parisons (9) have shown that Pic and its alleles are most similar
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to the SPATE proteins Tsh from avian pathogenic E. coli (43),
an identical protein termed Hbp from a human pathogenic
isolate (33), and SepA from Shigella flexneri (3). Both Tsh (22)
and another SPATE from enterohemorrhagic E. coli, termed
EpeA (24), have been reported to be mucinolytic. These re-
ports demonstrate the potential for this group of the SPATE
proteins to contribute to pathogenesis, perhaps via mucus layer
interaction and mucosal colonization.
The streptomycin-treated mouse is a well-established model
for studying E. coli colonization and interactions with the mu-
cus layer; E. coli mutants with a reduced ability to penetrate
mucus (25, 27) and grow in mucus (45) have been shown to
exhibit colonization defects in this model. Here, we report that
EAEC isolates are able to efficiently colonize the mouse intes-
tine only when the animal is pretreated with streptomycin. In
addition, our studies suggest roles for dispersin and Pic in
intestinal colonization.
MATERIALS AND METHODS
Strains and plasmids. Isolated from a child with diarrhea in Lima, Peru, the
prototype EAEC 042 strain caused diarrhea in adult volunteers (29) and was
used for the generation of all isogenic strains. Strain 042 is naturally streptomycin
resistant. A streptomycin-resistant derivative of the commensal E. coli strain HS
(23) was generated by selection on Luria-Bertani (L) agar plates with 100 g/ml
streptomycin. Other strains and plasmids used for genetic manipulations are
listed in Table 1. Strains were grown in L broth or maintained on L agar with
ampicillin (100 g/ml), kanamycin (50 g/ml), nalidixic acid (50 g/ml), and
streptomycin (100 g/ml) as required. All antibiotics were purchased from Sigma
Chemical Co. (St. Louis, MO).
Construction of isogenic mutants in strain 042. Mutations in the genes aggR,
aap, air, and aafA were constructed by single-crossover integration of suicide
plasmid pJP5603, and all were described previously (7, 30, 40, 41) (Table 1).
The pic and set1AB loci are overlapping genes encoded on opposite strands; a
pic mutant was constructed in which pic is inactivated via exchange of the
catalytic serine with alanine, without disruption of setBA. The catalytic serine in
Pic was first changed to alanine by site-directed mutagenesis in pPic, a previously
described pACYC184 derivative containing a genomic fragment encoding full-
length pic, cloned from strain 042 (17) to yield strain pPicS258A. Site-directed
mutagenesis employed QuikChange according to the manufacturer’s protocols
(Stratagene, La Jolla, CA) and using 25 ng of plasmid template DNA, 125 ng of
primers PicMut-F and PicMut-R (Table 2), 0.5 mM deoxynucleoside triphos-
phate mix, 1 buffer, and 2.5 U Pfu Turbo DNA polymerase (Stratagene).
Cycling conditions were 95°C for 30 s, followed by 20 cycles of 95°C for 30 s, 55°C
for 1 min, and 68°C for 20 min. Confirmation of mutations by nucleotide se-
quencing was performed at the University of Maryland Biopolymer Core Facility.
To introduce this mutation into strain 042, an approximately 2-kb region encod-
ing the C-terminal half of the pic gene product in strain pPicS258A was amplified
with primers designated PicKmSphI-F and PicKmXbaI-R (Table 2) containing
restriction sites for SphI and XbaI. The PCR product was subcloned into the
SphI and XbaI sites in the suicide vector pCVD442 to generate pSMH1 and was
transformed into chemically competent SY327pir (8). Purified pSMH1 was
subsequently transformed into SM10pir (8) for mating with EAEC strain 042.
Allelic exchange was performed as described previously (8). The S258A point
mutation was verified by nucleic acid sequence analysis. To facilitate the recovery
of strains in coinfection experiments, a nalidixic acid-resistant derivative of strain
042PicS258A was generated by being plating on L agar containing 50 g/ml
nalidixic acid.
The pic gene was also insertionally inactivated in strain 042 using a similar
approach. To construct a site into which the kanamycin resistance gene would be
cloned, a NotI restriction site was inserted in pPic by inverse PCR analysis. The
reaction was performed as for site-directed mutagenesis, using primers PicNotI-F
and PicNotI-R (Table 2). Cycling conditions were 95°C for 30 s, followed by 18
cycles of 95°C for 30 s, 60°C for 1 min, and 68°C for 25 min. The PCR product
was gel purified, ligated, and transformed into DH5. The Tn5 aminoglycoside
3-O-phosphotransferase gene (aph3) encoding resistance to kanamycin was
amplified from pK18 with primers KanNotI-F and KanNotI-R (Table 2). The
1,029-bp product of this reaction was gel purified and cloned into the NotI site
in pPic to generate pPicaph3. A 3.1-kb region of pPicaph3 was then amplified
such that the kanamycin resistance gene would be flanked by 1 kb of the pic
sequence using the primers PicKmXbaI-F and PicKmXbaI-R (Table 2) contain-
ing restriction sites for XbaI. Allelic exchange was performed as described above.
Bacterial growth curves. Growth of strain 042 and its mutants in various
growth media was performed by subculturing overnight broth cultures into the
appropriate medium in triplicate and reading the optical density at 600 nm
(OD600) at various time points. Data represent the means of the three points.
Growth in minimal medium was performed in M9 medium with 1% glucose;
TABLE 1. Characteristics and source of host strains and plasmids used in this study
Strain or plasmid Relevant characteristic(s)a Source or reference
E. coli strains
042 Prototype EAEC strain (044:H18) lac, Sm Tc Cm 27
042PicS258A 042 Ser258 to Ala This study
042PicS258A (Nalr) Nal derivative of 042PicS258A This study
042 pic::aph3 042 Km insertion in pic This study
042 aap 042 harboring pJP5603 inserted into aap, Km 39
042 aafA 3.4.14 042 harboring TnphoA inserted into the aafA gene, Km 7
042 aggR 042 harboring pJP5603 inserted into aggR, Km 28
042 air 042 harboring pJP5603 inserted into air, Km 40
DH5 F 80dlacZM15 (lacZYA-argF)U169 endA1 recA1 hsdR17 supE44 thi-1 gyrA96
relA1 phoA
37
SY327pir (lac pro) argE (Am) rif nalA recA56 22
SM10pir thr thi leu tonA lacY supE recA::RP4-2-Tc::Mu (Km) 42
HS Commensal E. coli, Sm 18
Plasmids
pPic pACYC184 derivative containing an EcoRI-ScaI genomic fragment containing pic
cloned from EAEC strain 042, Tc
14
pPicS258A pPic, Ser 258 to Ala This study
pPic::aph3 pPic (Km insertion at Ala 254) This study
pCVD442 6.2-kb suicide vector, R6K origin, Ap 8
pSMH1 2-kb pPicS258A PCR product cloned into pCVD442 This study
pSMH2 3-kb pPicaph3 PCR product cloned into pCVD442 This study
pK18 Contains aminoglycoside 3-O-phosphotransferase (aph3) 34
a Ap, ampicillin resistance; Tc, tetracycline resistance; Cm, chloramphenicol resistance; Km, kanamycin resistance; Sm, streptomycin resistance; Nal, nalidixic acid
resistance; lac, lactose fermentation.
2466 HARRINGTON ET AL. INFECT. IMMUN.
 o
n
 O
ctober 31, 2018 by guest
http://iai.asm
.org/
D
ow
nloaded from
 
0.05% glucose was employed during experiments in which mucin was added. The
mucin used was bovine submaxillary mucin preparation obtained from Sigma
Chemical Co., St. Louis, MO.
Mouse colonization. The streptomycin-treated mouse model was adapted
from previous reports (26, 32). Eleven- to 12-week-old female BALB/c mice
(Charles River Laboratories, Wilmington, MA) were provided with drinking
water ad libitum containing 5 g/liter streptomycin from 24 to 48 h prior to
inoculation and for the duration of the experiment. Stool samples were docu-
mented to be free of streptomycin-resistant E. coli at the time of inoculation.
Inoculation strains were grown overnight in L broth, diluted 1:500, and incubated
to late exponential phase (approximately 6 h). Bacteria were pelleted by centrif-
ugation, washed once with sterile phosphate-buffered saline (PBS; pH 7.4), and
resuspended in PBS to a final concentration of 5  103 CFU/ml. For coinfec-
tions, a 1:1 mixed suspension of strain 042 and the mutant was prepared at a final
total concentration of 1  104 CFU/ml. Prior to infection with bacterial strains,
mice were given 0.2 ml half-saturated sodium bicarbonate solution orogastrically
to neutralize gastric acid. Approximately 15 min later, 0.2 ml of the inoculum was
administered orogastrically. Bacterial inocula were quantified by plate counts.
Fresh fecal pellets were collected at the indicated time points for up to 15 days
postinfection. Feces were weighed, diluted, and homogenized in sterile PBS;
serial dilutions were plated on MacConkey agar (Sigma) with antibiotics. Anti-
biotic concentrations used in these media were 100 g/ml streptomycin for strain
042, 100 g/ml streptomycin and 10 g/ml nalidixic acid for strain 042PicS258A,
or 100 g/ml streptomycin and 25 g/ml kanamycin for all other mutants. The
limit of detection was approximately 103 CFU/g feces. For cultures in which
colony counts were less than the lower limit of detection, statistical analysis was
performed with values set at the limit of detection.
For enumeration of bacteria in intestinal compartments, a 2- to 3-cm section
of the ileum that was approximately 1 cm away from the ileo-cecal valve, an
	2-cm length of the colon, and the entire cecum were excised. Lumenal contents
were expelled and weighed, and serial dilutions were made in PBS for plating to
MacConkey agar; bacterial counts were expressed as CFU/gram of intestinal
content. Intestinal segments were opened and rinsed thoroughly in PBS to
remove fecal material, homogenized in 1 ml PBS with a Handi-Shear tissue
homogenizer (VirTis, Gardiner, NY), and diluted in PBS for plating on Mac-
Conkey agar. For quantitation of bacteria colonizing the mucus layer, tissue was
washed with PBS and then the mucus layer was removed by being scraped with
a rubber spatula. Mucus was diluted in 200 l PBS, and serial dilutions were
plated on MacConkey agar. After being scraped, the tissue was homogenized and
bacterial counts were determined as described above.
Growth in cecal lumenal contents and in cecal mucus. The experiments de-
fining growth in mucus and cecal contents in vitro were performed as previously
described (46). Twenty CD-1 5-week-old male mice (Charles River Laboratories,
Wilmington, MA) were given pine shaving bedding, sterile water, and mouse and
rat diet (Harlan Teklad, Madison, WI) and acclimatized to the facilities for
approximately 1 week. Mice were given 5 g/liter streptomycin sulfate in their
drinking water, provided ad libitum, for 1 day. Ten mice were asphyxiated using
CO2, and their ceca were excised; contents were collected into a 15-ml tube kept
on ice. The cecal tissue was then rinsed in a petri dish filled with ice-cold
HEPES-Hanks’ buffer (HHB; 8 g NaCl, 0.4 g KCl, 0.14 g CaCl2  2H2O, 0.20 g
MgSO4  7H2O, 0.05 g Na2HPO4, 0.35 g KH2PO4, 2.6 g HEPES per liter). Ceca
were blotted dry on paper towels, and mucus was scraped off of the tissue into a
petri dish using a soft rubber policeman; mucus from these 10 mice was pooled
for later use.
Overnight L broth bacterial cultures were grown at 37°C in a shaking water
bath. One milliliter of cells from E. coli strains 042 and 042PicS258A was pelleted
at 10,000 rpm for 1.5 min. The pellet was rinsed with cold HHB and resuspended
in 1 ml HHB. The washed bacteria were mixed together and inoculated into the
pooled mucus sample or the pooled cecal contents to produce a final inoculum
concentration of 104 CFU/ml. Following inoculation, the mucus or cecal cultures
were incubated overnight at 37°C in a shaking water bath. At each time point, 50
l was removed, diluted 10-fold in HHB, and plated on MacConkey agar plates
containing 100 g/ml streptomycin sulfate or 100 g/ml streptomycin sulfate and
50 g/ml nalidixic acid. Plates were incubated at 37°C overnight. From the
cultures in mucus, samples were taken at time zero and at 2, 4, 6, 8, and 24 h.
From the cultures in cecal contents, samples were taken at time zero and at 24 h.
For longer incubation experiments, E. coli 042 and 042PicS258A were grown
to late logarithmic phase and added to mucus at a final concentration of 1  105
CFU/ml. Sampling from cultures was performed at 0, 6, 12, and 24 h and daily,
thereafter, for 6 days. Fresh streptomycin was added to the culture each day to
a final concentration of 50 g/ml.
Adherence to mouse colonic tissue. This protocol was adapted from the
method described by El Asmar et al. (10). Eleven- to 12-week-old female
BALB/c mice were given 5 g/liter streptomycin in their drinking water for 48 h
prior to collection of colonic tissue. Mice were anesthetized with isoflurane
(Abbott, Chicago, IL) and sacrificed by cervical dislocation. The entire colon was
excised and rinsed thoroughly in sterile PBS, pH 7.4. Tissue segments 	0.5 cm
in length were cut and placed mucosal side up onto polycarbonate filters cut from
a Snapwell tissue culture chamber (Corning Costar). The tissue and filter were
sandwiched between two plastic rings with a 3-mm-diameter central hole and
placed back into the Snapwell chamber. Tissues were equilibrated for 30 min at
37°C in an atmosphere of 5% CO2 in prewarmed Dulbecco’s modified Eagle
medium containing 4.5 g/liter glucose, L-glutamine, 110 mg/liter sodium pyru-
vate, and pyridoxine hydrochloride. Five milliliters of Dulbecco’s modified Eagle
medium was added to the serosal side and 200 l to the mucosal side of the tissue
in the chamber.
Bacterial strains were grown to late logarithmic phase, washed, and standard-
ized as described for previous studies. Following the tissue equilibration period,
5 l of 1  108 CFU/ml of each strain was added to the mucosal side of each of
three wells. Cocultures were also performed in triplicate using 5 l of a mixed
culture of strains 042 and 042PicS258A or 042 and 042 pic::aph3 with each strain
at 1  108 CFU/ml. Snapwell chambers were incubated at 37°C for 3 h. After the
incubation period, chambers were washed five times with PBS to remove non-
adherent bacteria. Tissue was removed and homogenized in 200 l PBS in
Eppendorf tubes with plastic pestles using a pellet pestle motor (Kontes). Ho-
mogenates were diluted and plated on MacConkey media as described above.
Adherent bacteria were quantified as CFU/tissue segment because the area of
tissue available for bacterial adherence was identical for each well.
Growth competition assay in a continuous-flow fermentor. EAEC strains 042
and 042PicS258A were grown simultaneously in a continuous-flow anaerobic
culture either with or without introduction of a human fecal sample as previously
described (37) The fecal sample comprised 60 g of fresh stool from a healthy
human subject. After addition of the fecal sample, the system was stabilized for
at least 24 h at pH 6.5. Following the stabilization period, the system was
inoculated with 50 ml of a mixed culture of strains 042 and 042PicS258A to a final
concentration of 107 CFU/ml each. The continuous-flow culture was sampled at
6, 12, and 24 h and once a day for 5 days postinoculation. Samples were diluted
and plated on MacConkey media with appropriate antibiotics. Culture plates
were incubated, and strains were quantified as described for previous experi-
ments.
Statistical analysis. Analyses were performed on log-transformed data for all
colony counts, employing software available at the Universiteit van Amsterdam
TABLE 2. Primers for construction of pic mutants
Primer designation Sequencea
PicMut-F...............................................................................................5-GGAGCCCCTGGGGATGCTGGTTCTCCTTTGTTTGC
PicMut-R..............................................................................................5-GCAAACAAAGGAGAACCAGCATCCCCAGGGGCTCC
PicNotI-F..............................................................................................5-AAGGAAAAAAGCGGCCGCGCCTGGGGATAGTGGTTCTCCTTTG
PicNotI-R .............................................................................................5-AAGGAAAAAAGCGGCCGCGGCTCCATAGTCAGGTAAAGGGCCG
KanNotI-F............................................................................................5-AAGGAAAAAAGCGGCCGCGCTTGCAGTGGGCTTACATG
KanNotI-R ...........................................................................................5-AAGGAAAAAAGCGGCCGCCGGTCATTTCGAACCCCAGAG
PicKmSphI-F .......................................................................................5-ACATCCATGCCTGGCATTAAGGCTACATACGGC
PicKmXbaI-R ......................................................................................5-CTAGTCTAGACTGAGCCGGATCATTCAGGCTG
PicKmXbaI-F.......................................................................................5-CTAGTCTAGACTGGCATTAAGGCTACATACGGC
PicKmXbaI-R ......................................................................................5-CTAGTCTAGACTGAGCCGGATCATTCAGGCTG
a Underlined nucleotides indicate the Ser-to-Ala mutation site.
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website (www.fon.hum.uva.nl/). The paired t test was used to compare means of
log-transformed data from different sites of the mouse intestine. For the adher-
ence assay involving multiple comparisons, statistical analysis was performed
with a one-way analysis of variance, followed by Bonferroni error correction,
using the Analyze-it add-in for Microsoft Excel database software. For in vitro
growth experiments, means of log10 CFU per milliliter were compared by using
the paired Student’s t test (two-tailed) using Excel database software.
RESULTS
Colonization of BALB/c mice with EAEC. We infected 11- to
12-week-old BALB/c mice with high doses of EAEC after
neutralization of gastric acidity. We found that EAEC strain
042 colonized inconsistently and was often eliminated within 3
days of inoculation. Excretion levels ranged from 0 to 105
CFU/g of feces, typically higher during the first day after in-
oculation. All mice remained clinically well with normal intes-
tinal histopathology.
The streptomycin-treated mouse model has been used to
study intestinal colonization with E. coli and Salmonella spp.
(32, 45), and the model has recently been shown to be useful
for inducing colitis with Salmonella strains (44). The prototype
strain 042 is naturally resistant to streptomycin. Mice were
given water containing 5 g/liter streptomycin ad libitum for 24
to 48 h prior to inoculation and for the duration of the exper-
iment. Strain 042 colonized streptomycin-treated mice consis-
tently, at levels of approximately 108 to 109 CFU/g of stool.
Mice remained colonized as long as streptomycin was provided
in the water, though they commonly cleared colonization when
streptomycin was removed. All mice remained well. His-
topathologic examination of infected mice was normal.
Effects of EAEC adherence factors on mouse gastrointesti-
nal (GI) colonization. Since streptomycin treatment resulted in
high levels of colonization, we sought to determine whether the
model could be used to assess the contribution of putative
EAEC colonization factors. We tested mutants in the AAF/II-
encoding genes, the global regulator AggR, the dispersin coat
protein, and a recently discovered agglutinin called Air for the
ability to colonize streptomycin-treated mice.
An inoculum of 1  103 CFU of each strain was introduced
individually to groups of four to eight mice, and fecal coloni-
zation was quantified for up to 12 days. All mutants were able
to colonize streptomycin-treated mice when fed individually at
levels not significantly different from that of strain 042 (data
not shown).
Competition between the mutants and the wild-type strain
was then employed as a more sensitive readout of colonization
efficiency. Accordingly, mice were infected simultaneously with
1  103 CFU each of strain 042 and one of the isogenic
mutants. Isogenic strains with mutations in aafA, air, and sur-
prisingly aggR cocolonized at levels similar to that of the wild-
type parent. However, strain 042 aap, which contains a muta-
tion in the gene encoding the dispersin protein coat and which
displays a hyperaggregative phenotype in vitro, was consis-
tently deficient in colonization compared to the wild-type par-
ent (Fig. 1).
Pic contributes to colonization. In addition to testing mu-
tants in adherence-related factors, we also addressed the po-
tential role of the Pic mucinase in intestinal colonization of the
streptomycin-treated mouse. For these initial studies, we uti-
lized a mutant in which the aph3 gene was inserted into pic. As
with the adherence factors, strain 042 pic::aph3 showed no
defect in colonization of the streptomycin-treated mouse when
tested independently.
In competition experiments, however, strain 042 pic::aph3
was outcompeted by the wild type (Fig. 2a). Colonization of
the wild-type parent strain reached 	1  108 CFU/g feces
within the first 2 days after inoculation and was generally
maintained for the duration of the experiment. With the pic
mutant, however, most of the mice colonized initially to a level
of 	1  107 to 1  108 CFU/g feces over the first several days.
However, colonization was not maintained thereafter, declin-
ing around day 7 and reaching a level of 	1  104 to 1  105
CFU/g after day 10. By the last 5 days of the experiment, there
existed a 2- to 3-log10 difference in colonization between
strains 042 and 042 pic::aph3.
Since Pic is encoded in overlapping configuration with genes
encoding the ShET1 enterotoxin, the defect of our mutant
could have been due to disruption of ShET1 and/or Pic pro-
duction. Attempts to complement the mutant in trans were
unsuccessful, as the complemented strain did not grow as well
as the mutant in vitro. We therefore constructed a pic mutant
that would disrupt protease function but allow production of a
noncatalytic Pic protein and an unmodified ShET1; the con-
struction employed the allelic exchange of a single nucleotide
to replace the Pic catalytic serine with alanine, retaining the
native amino acid sequence on the opposite strand. This mu-
tant was designated 042PicS258A.
In competition experiments with the wild-type strain,
042PicS258A was also impaired in colonization. The parent
colonized at a level of 1  108 to 1  109 CFU/g feces by 40 h
postinfection; this was maintained for 15 days on streptomycin
(Fig. 2b). Strain 042PicS258A, however, was not able to main-
tain a high level of colonization. While colonization in some
mice was as high as 1  107 CFU/g feces for the first few days
after inoculation, bacterial counts of the mutant gradually de-
clined toward the lower limit of detection (	1  103 CFU/g).
For several mice, detectable colonization with the mutant was
never established. At all time points beyond day 2, a significant
FIG. 1. Coinfection of streptomycin-treated mice with E. coli strain
042 and the dispersin mutant 042 aap. Mice were infected simulta-
neously with 2  103 CFU of each strain. The bacteria were individ-
ually quantitated in fresh fecal pellets on days 1, 3, and 4. Graph
represents a typical experiment with six mice in each group; bars
represent the mean ratio of wild type to mutant.
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difference (3 to 5 log10) in fecal colonization was observed
between strains 042 and 042PicS258A. Thus, two indepen-
dently constructed mutations in pic demonstrated significant
and consistent defects in colonization of the mouse GI tract
compared with their parent strains.
Sites of colonization by strains 042 and 042PicS258A. We
sought to characterize further the mechanism of Pic’s contri-
bution to colonization. We performed competition experi-
ments in the streptomycin-treated mouse model, quantitated
the inoculated strains in the intestinal lumen, within the co-
lonic mucous layer, and associated with the tissue underlying
the mucous layer.
Five mice were infected simultaneously with 1  103 CFU of
strains 042 and 042PicS258A and sacrificed at 24 h and at 3
days postinfection. These time points were chosen to evaluate
the distribution of strains very early in colonization and when
the mutant was found in highest numbers in the feces (day 3).
At 24 h postinoculation, we found higher numbers of strain 042
than 042PicS258A in the lumina of both the cecum and colon;
few cells of either bacterium were found in the ileum. At this
early time point, no strain 042PicS258A cells and compara-
tively low numbers of strain 042 (	1  104 in two mice) were
detected adherent to tissues of the cecum and colon. Whereas
strain 042 was more adherent at the 24-h time point, the low
level of colonization limited our ability to draw statistically
significant inferences.
By 3 days postinfection, EAEC bacteria were present in the
ileum, cecum, and colon, but as on day 1, colonization of both
strains was higher in the cecum and colon than in the ileum
(Table 3). For the cecum and colon, the median CFU/g for
strain 042 was approximately 3 log10 greater than the pic mu-
tant. This ratio of wild-type to mutant bacteria was consistently
observed in the tissues and lumenal contents of the cecum and
colon.
To further address the potential roles of penetration and
adherence, the mucous layer was scraped from a section of
colon in each of the five mice, and the wild type and pic mutant
were enumerated in the mucus and underlying colonic tissue.
At 24 h, no strain 042PicS258A cells were detected and only
rarely were strain 042 cells detected (in one mouse) adherent
to tissues and in the mucous layer. In contrast, on day 3, there
was an approximately 2-log10 difference between the median
CFU/g of the two strains in both the scraped mucus and un-
derlying colon tissue (Table 3).
Thus, the higher proportion of the wild type versus the
mutant was consistently observed in the lumen, mucus layer,
and underlying tissue. That difference was present in the lumen
by 24 h postinfection and in the lumen, mucous layer, and
underlying tissue by 3 days postinfection.
Adherence to mouse colonic tissue by strain 042 and mu-
tants. We next evaluated the relative abilities of the wild type
FIG. 2. Coinfection of streptomycin-treated mice with E. coli strain
042 and pic mutants. (a) Eight female BALB/c mice were infected
simultaneously with 1 103 CFU of EAEC strain 042 (f) or strain 042
pic::aph3 (E). Data points are log10 CFU/g of fresh fecal sample
collected from each mouse on days 1, 2, and 3 and approximately every
other day for 15 days. The line shows the median log10 CFU/g feces. A
P value of0.0156 was recorded for the difference between strains 042
and 042 pic::aph3 on days 2 to 15 (except day 7) by the Wilcoxon
matched-pairs signed-ranks test. (b) Nine female BALB/c mice were
infected simultaneously with 1 103 CFU of EAEC strain 042 (f) and
strain 042PIC258A (E). A P value of 0.0039 was recorded for the
difference between strains 042 and 042PicS258A in the matched-pairs
signed-ranks test.
TABLE 3. Competitive colonization on day 3 postinfectiona
Location of colonization
Bacterial counts of indicated strain in luminal
contents (log10 CFU/g)
P valueb
Bacterial counts of indicated strain in
homogenized tissue (log10 CFU/g)
P valueb042 042PicS258A 042 042PicS258A
Mean Median Mean Median Mean Median Mean Median
Ileum 4.5 
 2.1 3.0 3.0 
 0.0 3.0 1.0 3.7 
 0.9 3.2 3.0 
 0.0 3.0 1.0
Cecum 8.6 
 0.5 8.5 5.5 
 0.7 5.59 0.004 6.1 
 1.1 5.7 3.1 
 0.2 3.1 0.004
Colon with mucus layer 7.9 
 1.1 8.1 4.7 
 0.7 4.8 0.005 6.2 
 0.9 6.3 3.4 
 0.5 3.0 0.001
Colonic mucus layer 5.5 
 0.9 5.4 3.0 
 0.0 3.0 0.01 5.5 
 0.9 5.5 3.1 
 0.1 3.0 0.003
a Five mice were given 1  103 CFU of strains 042 and 042PicS258A simultaneously. Numbers in the table are the means 
 1 standard deviation and median log10
CFU/g tissue or per milliliter of contents at 3 days postinfection. Limit of detection was approximately 1  103 CFU/g. If no organisms were detected, mean and median
are recorded as 3.0 log10 CFU/g.
b P values for the difference between the mean colonization of strains 042 and 042PicS258A for each site were determined by using the paired t test of log-transformed
data. If none was detected, the P value is based on 3 log10 CFU/g.
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and mutant to adhere to fresh colonic tissue excised from a
streptomycin-treated mouse in an ex vivo format, using the
previously described Snapwell system (10), in which tissue is
mounted between two plastic disks and bathed in cell culture
medium with separation of mucosal and serosal surfaces into
distinct compartments. EAEC strains were more adherent to
the mouse colonic mucosa than commensal E. coli HS; how-
ever, there was no difference in the ability of strain 042,
042PicS258A, or 042 pic::aph3 to adhere to the tissue when
cultured individually (data not shown). Similarly, coculture of
strain 042 with either mutant strain did not show any differ-
ences in relative adherence.
In vitro growth characteristics of pic mutants. Either indi-
vidually or in coculture, the pic mutants grew at rates similar to
that of their wild-type parent in L broth cultures. Both mutants
retained the ability to form a biofilm on polystyrene (42) and
displayed motilities similar to that of the parent strain (data
not shown).
We addressed whether the colonization deficiency of the pic
mutants could be due to differences in anaerobic growth. To
test this hypothesis, we employed the continuous-flow anaer-
obic culture system established in our laboratory to simulate
the microenvironment of the human colon (37). The growth
medium for these experiments has been established for EAEC
strain 042 (37). An advantage of this system is that the growth
characteristics of a test strain can be assessed in the presence
or absence of other fecal bacteria.
The culture system was equilibrated with a human fecal
sample and then inoculated with a mixed culture of 042 and
042PicS258A to a concentration of 	1  107 CFU/ml of each
strain. Growth of each strain was monitored for 5 days. Colony
counts gradually declined for 48 h but then stabilized at 	1 
105 to 1  106 CFU/ml. No significant difference in growth
between the wild type and the pic mutant was observed (Fig.
3a). We then repeated these experiments but without the ad-
dition of the fecal inoculum. Without competition from other
bacteria, EAEC increased in numbers for the first 12 h and
then declined to a steady-state level of 	6.5 log10 CFU/ml
(Fig. 3b). Again, no significant difference between the wild type
and mutant was seen. The competitive advantage of strain 042
in vivo was therefore not reproduced with the intestinal simulator,
suggesting that the advantage conferred by the Pic protein was
due to neither enhanced fitness for anaerobic growth nor im-
proved competition with typical human commensal flora.
Growth in cecal mucus and lumenal contents. As a muci-
nase, Pic could hypothetically enhance fitness via improved
use of nutrients derived from some lumenal component,
perhaps mucin itself. We therefore evaluated growth in mu-
cus and cecal lumenal contents harvested from the intestines
of mice. Lumenal contents and mucus were extracted sepa-
rately and inoculated with 1  104 CFU of strains 042 and
042PicS258A and then cultured aerobically and sampled
over time.
As shown in Fig. 4, the strains grew similarly for the first 6 h
of cocultivation, with similar generation times of 33 to 40 min.
However, at the 8-h time point and subsequently, growth of
strain 042PicS258A slowed, with a generation time increasing
to 53 min at 6 to 8 h; in contrast, strain 042 continued to grow
in mucus for the duration of the experiment, and the 6- to 8-h
generation time was approximately 32 min. Growth in cecal
contents for both strains was slow, yet numbers increased for
strain 042 over the 24 h of the experiment and declined slightly
for strain 042PicS258A. This experiment was repeated using
longer incubation times; the difference in growth between the
FIG. 3. Growth of strain 042 (f) and strain 042PicS258A (E) in a
mixed culture in a continuous-flow anaerobic culture system with hu-
man fecal bacteria (a) or without addition of a human fecal sample (b).
Growth is expressed as means 
 1 standard deviation log10 CFU/ml of
two samples removed from the system at the indicated time points.
FIG. 4. Relative growth in cecal mucus and cecal contents. Tubes
containing cecal mucus (filled symbols) or cecal contents (open sym-
bols) were inoculated simultaneously with a mixture of 104 CFU of
strain 042 (squares; solid lines) and 104 CFU of strain 042PicS258A
(circles; dashed lines) and incubated at 37°C with aeration. At the
times indicated, tubes were sampled to determine viable counts. Bars
representing the standard error of the mean log10 CFU/ml for dupli-
cate experiments are presented for each time point.
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two strains in mucus was reproducible and remained significant
up to 48 h (data not shown).
The fact that strains 042 and 042PicS258A grew similarly
in mucus for several hours, after which time strain 042
exhibited superior growth, suggested that Pic was providing
some metabolic advantage to the bacterium, presumably
after the exhaustion of a more readily available nutrient. An
alternative hypothesis was that mucin was inhibiting the
growth of the bacterium, with this inhibition being relieved
by Pic. To test these alternative hypotheses, we character-
ized growth curves of strain 042 versus strain 042PicS258A
in M9 minimal medium containing 0.05% glucose to which
bovine submaxillary mucin was added during logarithmic
phase (after 5 h of growth). As shown in Fig. 5, strains 042
and 042PicS258A entered stationary growth phase at similar
times. However, the wild type then resumed slow growth for
several additional hours, whereas the Pic mutant remained
at a uniform OD600.
DISCUSSION
Our studies suggest that the streptomycin-treated mouse
model has some advantages and some limitations for the study
of EAEC colonization factors. The AAF/II fimbriae of strain
042 are essential for adherence to the human intestine ex vivo
but were not shown to confer a colonization advantage in the
mouse. This is in spite of our observation that AAF/II fimbriae
enhance adherence to the mouse intestinal mucosa in vitro.
Why adherence does not translate into increased colonization
is not apparent. Interestingly, however, the dispersin protein
required for normal morphology of the AAF adhesins and
which modulates EAEC aggregation was found to be required
for efficient colonization. We have demonstrated previously
that EAEC bacteria lacking dispersin are highly aggregated
and move more slowly than bacteria of strain 042 through a
viscous column of purified mucin (40). The effect of the dis-
persin mutant in the mouse was apparently dependent on ex-
pression of the AAF adhesin, as the aggR mutant, unable to
make either dispersin or AAF, no longer exhibited any colo-
nization disadvantage. These experiments do not exclude a
role for an as-yet-unidentified AggR-dependent factor. Fur-
ther characterization of the contribution of dispersin will be
published elsewhere.
Our studies did not reveal a role for the newly discovered
chromosomally encoded aggregin, Air, which is under the con-
trol of the HilA-like regulator EilA (41). Like absence of
dispersin, the presence of Air promotes aggregation of bacte-
ria. It is interesting, therefore, that our data suggest no influ-
ence of Air on colonization of the mouse. It is possible that the
natural role of Air could be in EAEC adherence outside of the
host, or perhaps the role is complex and relevant at later stages
in the colonization process.
Given the occurrence of the Pic mucinase in EAEC, Shigella
spp., and UPEC strains, we were particularly interested in its
possible contribution to colonization. A number of studies
have demonstrated two stages of colonization for E. coli in the
streptomycin-treated mouse model (26, 46). When fed alone to
mice, low numbers of bacteria (1  105) will increase to be-
tween 1  108 and 1  109 CFU/g feces within 1 to 3 days
postinfection; this is postulated to be due to limited competi-
tion for nutrients from other aerobic species. After this initia-
tion phase, however, counts of E. coli will diminish to approx-
imately 1 107 to 1 108 CFU/g feces, where they will remain
indefinitely; this second stage has been termed the mainte-
nance stage (6). The maintenance stage is thought to represent
stable establishment of a metabolic niche within the intestine,
in which the bacteria metabolize some carbon sources better
than the incumbent microflora. When fed individually, both
strain 042 and two different pic mutants were able to colonize
to high numbers and remained stable for the 12 days of the
experiment, exhibiting normal initiation and maintenance
phases. However, when fed to mice simultaneously, the wild
type maintained its level of colonization at 1  107 to 1  108
CFU/g feces, whereas the pic mutants initiated infection in
some mice but failed to maintain it, gradually declining to
between 1  103 and 1  105 CFU/g feces. This reveals the
relative superiority of the wild type for maintaining coloniza-
tion of the GI niche and suggests a metabolic advantage of the
wild type.
We had initially speculated that the mechanism of Pic’s
effect would involve penetration of the mucus layer. However,
the superiority of the parent over its pic mutant was apparent
at all sites and environments of the GI tract, including at the
lumen and the mucus layer, as well as at the level of the
epithelial surface. Two bacterial metalloproteases have been
reported to have mucinase activity and also to contribute to
bacterial adherence. StcE, in enterohemorrhagic E. coli O157:
H7, promotes intimate adherence to HEp-2 cells (14), and Hap
FIG. 5. Pic enhances growth of strain 042 in the presence of mucin.
Thirteen-hour growth curves of wild-type strain 042 and strain
042PicS258A (042S) are shown in M9 minimal medium with 0.05%
glucose, with and without the addition of mucin after 5 h of incubation
(arrow). Results are typical of repeated experiments; measurements
are performed in triplicate with an error of 0.003 U for all points.
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of Vibrio cholerae acts as a detachase, freeing adherent bacteria
(2). However, we did not find evidence to suggest that the role
of Pic included adherence. Nor did our data suggest increased
fitness in aerobic or anaerobic environments, even in the pres-
ence of fecal bacteria.
In aggregate, our data are most consistent with a metabolic
role for Pic, dependent on its mucinase activity and presumably
by allowing the use of mucus as a growth substrate. Using the
streptomycin-treated mouse model, E. coli has been shown to
utilize gluconate in mucus as a major carbon source (45).
Notably, we found that EAEC strain 042 and its pic mutant
grew equally well in cecal mucus in vitro for approximately the
first 6 h, indicating that both strains utilize gluconate or an-
other nutrient equally during this time period. However, after
6 to 8 h, growth of the mutant slowed considerably, whereas
strain 042 continued rapid growth for at least 48 additional
hours. This model, therefore, recapitulated the in vivo effect.
In standard growth media, including M9 minimal medium con-
taining glucose, strain 042 and an isogenic mutant lacking only
the Pic catalytic serine grew equally well. However, when mu-
cin was added to the medium, strain 042 demonstrated more
robust growth, beginning after the initiation of stationary
phase. The similar growth rates early in the experiment suggest
that glucose may be a preferred substrate for both the wild type
and the pic mutant but that the use of mucus as a substrate
occurs when other preferred substrates are limiting; limitation
may prevail either because preferred substrates are not present
at that intestinal site or because they are more efficiently uti-
lized by competing microflora.
Our data therefore strongly support the hypothesis that the
contribution of Pic to intestinal colonization is nutritional. The
fact that both the wild type and the Pic mutant grow well
initially in mouse mucus preparations prior to the deviation of
the growth curves supports this interpretation of the data.
Whether the postulated advantage of Pic occurs via the release
of glycans from intestinal mucus and/or from degradation of
the mucin protein backbone cannot be determined from our
data, and it is the subject of ongoing studies in our laboratories.
Moreover, the presence of Pic in Shigella spp. and UPEC
strains and the presence of mucinolytic Pic homologs in other
pathogens suggest that our observations may have implications
for pathogens other than EAEC.
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